Staphylococcus aureus is a crucial human pathogen expressing various immune-evasion proteins that interact with the host-cell molecules. Clumping factor A (ClfA) is a microbial surface protein that promotes S. aureus binding to fibrinogen, and is associated with septic arthritis and infective endocarditis. In order to identify the major human serum proteins that bind the ClfA, we utilized recombinant ClfA region A in a plate-based assay. SDS-PAGE analysis of the bound proteins yielded five prominent bands, which were analysed by MS yielding apolipoprotein E (ApoE) as the predominant protein. ClfA-sufficient S. aureus bound purified ApoE by more than one log greater than an isogenic ClfA-deficient mutant. An immunodot-blot assay yielded a linearity model for ClfA binding to human ApoE with a stoichiometric-binding ratio of 1.702 at maximal Pearson's correlation coefficient (0.927). These data suggest that ApoE could be a major and novel binding target for the S. aureus virulence factor ClfA. Thus, ClfA recruitment of serum ApoE to the S. aureus surface may sequester ApoE and blunt its host defence function against S. aureus-invasive infections to humans. In this context, compounds that can block or suppress ClfA binding to ApoE might be utilized as prophylactic or therapeutic agents.
ArciolaC. R., BaldassarriL., MontanaroL.2001; Presence of icaA and icaD genes and slime production in a collection of staphylococcal strains from catheter-associated infections. J Clin Microbiol 39:2151–2156 [View Article][PubMed]
CunnionK. M., LeeJ. C., FrankM. M.2001; Capsule production and growth phase influence binding of complement to Staphylococcus aureus. Infect Immun 69:6796–6803 [View Article][PubMed]
de BontN., NeteaM. G., DemackerP. N., VerschuerenI., KullbergB. J., van DijkK. W., van der MeerJ. W., StalenhoefA. F.1999; Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J Lipid Res 40:680–685[PubMed]
Do CarmoS., JacomyH., TalbotP. J., RassartE.2008; Neuroprotective effect of apolipoprotein D against human coronavirus OC43-induced encephalitis in mice. J Neurosci 28:10330–10338 [View Article][PubMed]
DobsonC. B., SalesS. D., HoggardP., WozniakM. A., CrutcherK. A.2006; The receptor-binding region of human apolipoprotein E has direct anti-infective activity. J Infect Dis 193:442–450 [View Article][PubMed]
FaghriJ., ShahbazzadehD., Pooshang BagheriK., MoghimS., Ghasemian SafaeiH., Nasr EsfahaniB., FazeliH., YazdaniR., Mirmohammad SadeghiH.2012; Two dimensional structural analysis and expression of a new Staphylococcus aureus adhesin based fusion protein. Iran J Basic Med Sci 15:725–738[PubMed]
HairP. S., WardM. D., SemmesO. J., FosterT. J., CunnionK. M.2008; Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b. J Infect Dis 198:125–133 [View Article][PubMed]
HairP. S., EchagueC. G., ShollA. M., WatkinsJ. A., GeogheganJ. A., FosterT. J., CunnionK. M.2010; Clumping factor A interaction with complement factor I increases C3b cleavage on the bacterial surface of Staphylococcus aureus and decreases complement-mediated phagocytosis. Infect Immun 78:1717–1727 [View Article][PubMed]
HakimH., MylotteJ. M., FadenH.2007; Morbidity and mortality of staphylococcal bacteremia in children. Am J Infect Control 35:102–105 [View Article][PubMed]
HauptK., ReuterM., van den ElsenJ., BurmanJ., HälbichS., RichterJ., SkerkaC., ZipfelP. F.2008; The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement factor H and C3b. PLoS Pathog 4:e1000250 [View Article][PubMed]
HawkinsJ., KodaliS., MatsukaY. V., McNeilL. K., MininniT., ScullyI. L., VernachioJ. H., SeverinaE., GirgentiD. et al.2012; A recombinant clumping factor A-containing vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposure. Clin Vaccine Immunol 19:1641–1650 [View Article][PubMed]
JamesE. H., EdwardsA. M., WigneshwerarajS.2013; Transcriptional downregulation of agr expression in Staphylococcus aureus during growth in human serum can be overcome by constitutively active mutant forms of the sensor kinase AgrC. FEMS Microbiol Lett 349:153–162 [View Article][PubMed]
Jofre-MonsenyL., MinihaneA. M., RimbachG.2008; Impact of apoE genotype on oxidative stress, inflammation and disease risk. Mol Nutr Food Res 52:131–145 [View Article][PubMed]
JosefssonE., HartfordO., O’BrienL., PattiJ. M., FosterT.2001; Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J Infect Dis 184:1572–1580 [View Article][PubMed]
KuwaharaT., KanedaS., ShimonoK., InoueY.2010; Growth of microorganisms in total parenteral nutrition solutions without lipid. Int J Med Sci 7:43–47 [View Article][PubMed]
MasagoY., ShibataT., RoseJ. B.2008; Bacteriophage P22 and Staphylococcus aureus attenuation on nonporous fomites as determined by plate assay and quantitative PCR. Appl Environ Microbiol 74:5838–5840 [View Article][PubMed]
McAdowM., KimH. K., DedentA. C., HendrickxA. P., SchneewindO., MissiakasD. M.2011; Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood. PLoS Pathog 7:e1002307 [View Article][PubMed]
McCormackN., FosterT. J., GeogheganJ. A.2014; A short sequence within subdomain N1 of region A of the Staphylococcus aureus MSCRAMM clumping factor A is required for export and surface display. Microbiology 160:659–670 [View Article][PubMed]
MiajlovicH., FallonP. G., IrvineA. D., FosterT. J.2010; Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus. J Allergy Clin Immunol 126:1184–1190 [View Article][PubMed]
MoreillonP., EntenzaJ. M., FrancioliP., McDevittD., FosterT. J., FrançoisP., VaudauxP.1995; Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun 63:4738–4743[PubMed]
PetersonM. M., MackJ. L., HallP. R., AlsupA. A., AlexanderS. M., SullyE. K., SawiresY. S., CheungA. L., OttoM., GreshamH. D.2008; Apolipoprotein B is an innate barrier against invasive Staphylococcus aureus infection. Cell Host Microbe 4:555–566 [View Article][PubMed]
RoselaarS. E., DaughertyA.1998; Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo. J Lipid Res 39:1740–1743[PubMed]
RosenthalV. D., MakiD. G., JamulitratS., MedeirosE. A., TodiS. K., GomezD. Y., LeblebiciogluH., Abu KhaderI., Miranda NovalesM. G. et al.2010; International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009. Am J Infect Control 38:95–104, e2 [View Article][PubMed]
SharpJ. A., CunnionK. M.2011; Disruption of the alternative pathway convertase occurs at the staphylococcal surface via the acquisition of factor H by Staphylococcus aureus. Mol Immunol 48:683–690 [View Article][PubMed]
SharpJ. A., EchagueC. G., HairP. S., WardM. D., NyalwidheJ. O., GeogheganJ. A., FosterT. J., CunnionK. M.2012; Staphylococcus aureus surface protein SdrE binds complement regulator factor H as an immune evasion tactic. PLoS ONE 7:e38407 [View Article][PubMed]
SinghI. P., ChopraA. K., CoppenhaverD. H., AnanatharamaiahG. M., BaronS.1999; Lipoproteins account for part of the broad non-specific antiviral activity of human serum. Antiviral Res 42:211–218 [View Article][PubMed]
Van OostenM., RensenP. C., Van AmersfoortE. S., Van EckM., Van DamA. M., BreveJ. J., VogelT., PanetA., Van BerkelT. J., KuiperJ.2001; Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality. A new therapeutic approach to treat gram-negative sepsis. J Biol Chem 276:8820–8824 [View Article][PubMed]
WalshE. J., O’BrienL. M., LiangX., HookM., FosterT. J.2004; Clumping factor B, a fibrinogen-binding MSCRAMM (microbial surface components recognizing adhesive matrix molecules) adhesin of Staphylococcus aureus, also binds to the tail region of type I cytokeratin 10. J Biol Chem 279:50691–50699 [View Article][PubMed]